First 'Digital Drug' Faces a Second Litmus Test: Improving Adherence

First 'Digital Drug' Faces a Second Litmus Test: Improving Adherence

Technology like this could expand further to form better collaborations between pharma, payers and organized providers.

What does Twitter's 280 characters mean for pharma?

What does Twitter's 280 characters mean for pharma?

Marketers survey the pluses and minuses of the platform's new 280-character limit.

Five things for pharma marketers to know: Thursday, November 2, 2017

Five things for pharma marketers to know: Thursday, November 2, 2017

Teva reports lower-than-expected Q3 earnings; BI and Dicerna partner in NASH drug development; AstraZeneca's experimental asthma drug fails in Phase-III

Who's Getting Rich in Healthcare?

Who's Getting Rich in Healthcare?

Do you recall what President Trump tweeted right after Merck's Kenneth Frazier resigned from his American Manufacturing Council?

Wellpepper wins Alexa Diabetes Challenge

Wellpepper wins Alexa Diabetes Challenge

The health startup's system has a foot scanner that can take photos of a patient's feet and can look for potential foot ulcers using a machine learning image classifier.

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.

AI Drug Design Could Save Lives

AI Drug Design Could Save Lives

AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.

Ready or not, Amazon is Coming

Ready or not, Amazon is Coming

The e-giant is reportedly doing everything from starting secret labs and online pharmacies to redefining the hospital experience and democratizing health data.

One-quarter of global marketers report digital ads next to extremist content

One-quarter of global marketers report digital ads next to extremist content

Some of the world's marketers have reported specific examples of where their digital advertising appeared alongside offensive and compromising content.

How Pablo Graiver plans to solve the problem of clinical-trial recruitment

How Pablo Graiver plans to solve the problem of clinical-trial recruitment

The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.

Online patient communities consider the platform: Facebook, or somewhere more private?

Online patient communities consider the platform: Facebook, or somewhere more private?

Facebook itself has more than six million health-related groups.

Accessible website design for users with disabilities lags far behind demand

Accessible website design for users with disabilities lags far behind demand

Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.

Is your brand's voice, male, female, human or mineral?

Is your brand's voice, male, female, human or mineral?

The rise of voice technology platforms and the connected home has turned the discussion of a brand's voice from metaphorical to physical.

Sheryl Sandberg: 'Facebook must bring people together to do good'

Sheryl Sandberg: 'Facebook must bring people together to do good'

Facebook chief operating officer Sheryl Sandberg has said that in turbulent times the social network must do more than simply connect people.

Fitbit CMO Tim Rosa: 'We know consumers don't want the internet on their wrists'

Fitbit CMO Tim Rosa: 'We know consumers don't want the internet on their wrists'

Rosa talks about the wearable technology company's health and fitness plans and other areas of expansion.

Five things for pharma marketers to know: Tuesday, September 12, 2017

Five things for pharma marketers to know: Tuesday, September 12, 2017

Alexion to cut 600 jobs; Sage Therapeutics' experimental seizure drug fails to meet expectations; Apple is interested in medical and health activity

Five things for pharma marketers to know: Monday, September 11, 2017

Five things for pharma marketers to know: Monday, September 11, 2017

Teva names new CEO; Allergan transfers Restasis patent to skirt competition; Google invests in oncology

Digital Healthcare: Is It For Real?

Digital Healthcare: Is It For Real?

The coming digital revolution will change a lot of things, but I guarantee this: It won't replace the importance of the patient-physician relationship.

Why use health plan apps? To search for specialists and understand drug coverage

Why use health plan apps? To search for specialists and understand drug coverage

Consumers younger than the age of 45 were most likely to use an app developed by their health plan.

Experts say pharma's move to Snapchat is in the making

Experts say pharma's move to Snapchat is in the making

Alone among the best-known social platforms, Snapchat has failed to generate much enthusiasm from pharma. Here's why — and here's why that may change.

Former Cleveland Clinic comms exec Angela Calman joins IBM Watson Health

Former Cleveland Clinic comms exec Angela Calman joins IBM Watson Health

Calman is joining the technology company as VP of comms for Watson Health.

Facebook ramps up video offer with revamped Watch tab

Facebook ramps up video offer with revamped Watch tab

Facebook is ramping up its video offering as a stronger rival to YouTube and Snapchat with the launch of its redesigned video tab.

Infographic | What patients want: a better healthcare experience

Infographic | What patients want: a better healthcare experience

Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.

Drugmakers test out Tumblr, to tap specific audiences

Drugmakers test out Tumblr, to tap specific audiences

Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That's about to change.

Five things for pharma marketers to know: Wednesday, August 2, 2017

Five things for pharma marketers to know: Wednesday, August 2, 2017

Celgene and Agios secure FDA approval for AML drug Idhifa; GSK hires chief digital and technology officer; Pfizer wants tax reform before M&A engagement

Five things for pharma marketers to know: Monday, July 31, 2017

Five things for pharma marketers to know: Monday, July 31, 2017

FDA launches digital health pre-certification pilot; J&J's experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi

Drugmakers turn to tech to better demonstrate empathy

Drugmakers turn to tech to better demonstrate empathy

Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.

Diabetes drugmakers partner with mobile startups to boost patient engagement

Diabetes drugmakers partner with mobile startups to boost patient engagement

Novo Nordisk and Roche are two examples of drugmakers that are turning to digital-health startups to better engage with patients and mine valuable real-world evidence.

Publicis Health: Privacy regs won't hamper Marcel's utility in pharma

Publicis Health: Privacy regs won't hamper Marcel's utility in pharma

Publicis Health CEO Nick Colucci talks to MM&M about whether the AI tool will get U.S. and European creative directors to collaborate.

One year later: How Pokémon Go leveled up AR for marketing

One year later: How Pokémon Go leveled up AR for marketing

The Pikachu-catching phenomenon popularized AR and made the technology much more accessible.

Five things for pharma marketers to know: Thursday, July 13, 2017

Five things for pharma marketers to know: Thursday, July 13, 2017

AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge

Five things for pharma marketers to know: Tuesday, July 11, 2017

Five things for pharma marketers to know: Tuesday, July 11, 2017

Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics

Five things for pharma marketers to know: Friday, June 16, 2017

Five things for pharma marketers to know: Friday, June 16, 2017

Apple reportedly working to bring EMRs to iPhone; FDA to study disclosures in ads; Trump admin discussing drug price EO

Five things for pharma marketers to know: Thursday, June 15, 2017

Five things for pharma marketers to know: Thursday, June 15, 2017

Google invests in European biotechs; hospitals that restrict sales-rep visits more likely to prescribe cheaper generics; AI could help doctors with new research

Bayer aims to drive patient-HCP dialogue with data-sharing app for MS

Bayer aims to drive patient-HCP dialogue with data-sharing app for MS

The FDA-approved app will allow MS patients to share their medication injection history with HCPs.

Half of clinical-trial sites offer free transportation to patients

Half of clinical-trial sites offer free transportation to patients

Consent forms and reimbursement are the main deterrents of offering the service.

Voice assistants may ease EHR burden for docs, but challenges exist

Voice assistants may ease EHR burden for docs, but challenges exist

With physicians spending nearly four hours a day on their electronic health records, experts say voice assistants could help reduce their workload one day.

Five things for pharma marketers to know: Thursday, June 1, 2017

Five things for pharma marketers to know: Thursday, June 1, 2017

50% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera

Five things for pharma marketers to know: Friday, May 26, 2017

Five things for pharma marketers to know: Friday, May 26, 2017

FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes

Five things for pharma marketers to know: Thursday, May 25, 2017

Five things for pharma marketers to know: Thursday, May 25, 2017

Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug

Twitter launches DM cards for brands

Twitter launches DM cards for brands

Twitter has launched a customizable Direct Message Card that brands can use to promote and share the bots or other customer experiences they've created, while Snapchat and Instagram have launched stories updates.

Otsuka, Proteus refile their sensor-enabled drug

Otsuka, Proteus refile their sensor-enabled drug

The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.

Apple helps a blind drummer and nonverbal teen thrive in new spots

Apple helps a blind drummer and nonverbal teen thrive in new spots

Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.

Califf joins Verily, to help the firm address the needs of doctors

Califf joins Verily, to help the firm address the needs of doctors

Robert Califf stepped down from his role as FDA commissioner in January.

Five things for pharma marketers to know: Wednesday, May 17, 2017

Five things for pharma marketers to know: Wednesday, May 17, 2017

FDA requires boxed warning for J&J's Invokana; Amazon to reportedly hire GM to enter pharmacy industry; WannCry ransomware affects some health organizations

15 years later, a blind man sees his wedding, thanks to VR

15 years later, a blind man sees his wedding, thanks to VR

To demonstrate the power of goggles equipped with AR and VR, the assistive technology company recreated the event on Facebook Live this weekend.

Admetsys wins the 2017 MM&M Startup Showdown

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Merck, Takeda execs: Is AI the new bad app?

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Pharma faces its 'oh, shit' moment

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Day 2 at Health Datapalooza

Day 2 at Health Datapalooza

The market for health data and technology is growing, but the industry must also address concerns about privacy, standards, and diversity.

Day 1 at Health Datapalooza

Day 1 at Health Datapalooza

HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.

Five things for pharma marketers to know: Thursday, April 27, 2017

Five things for pharma marketers to know: Thursday, April 27, 2017

Novartis, Kaiser, and Qualcomm partner on heart-failure pilot; Novartis and GSK disclose DTC plans; cancer-treatment hype can be negative for patients

40 Different Ways to Reshape Healthcare

40 Different Ways to Reshape Healthcare

Healthcare's collision with lower-cost genetic sequencing, mobile tech, AI, and consumerization will transform the trajectory of how we live for the next 10 years.

A new tool seeks to educate docs about Parkinson's symptoms

A new tool seeks to educate docs about Parkinson's symptoms

The device could be used by physicians to better understand the severity of a patient's symptoms and elicit empathy.

Regeneron uses VR to humanize retinal disease

Regeneron uses VR to humanize retinal disease

The drugmaker saw a gap in patient-physician conversation about retinal disease.

Five things for pharma marketers to know: Monday, April 10, 2017

Five things for pharma marketers to know: Monday, April 10, 2017

Gilead receives approval to market Harvoni, Sovaldi to adolescents; OncoMed ends mid-stage trials for pancreatic cancer drug; researchers use facial recognition software to diagnose

Is a Crisis Brewing for Watson Health?

Is a Crisis Brewing for Watson Health?

In the wake of MD Anderson's costly failure with IBM's Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.

Susannah Fox, formerly of HHS

Susannah Fox, formerly of HHS

Susannah Fox is the former chief technology officer for HHS.

Dr. Mylene Yao, Univfy

Dr. Mylene Yao, Univfy

Dr. Mylene Yao is co-founder and CEO of Univfy.

Sam Frons, Addicaid

Sam Frons, Addicaid

Sam Frons is founder of Addicaid.

Stephanie Tilenius, Vida Health

Stephanie Tilenius, Vida Health

Stephanie Tilenius is CEO and co-founder of Vida Health.

Jenny Barnett, Cambridge Cognition

Jenny Barnett, Cambridge Cognition

Jenny Barnett is chief scientific officer at Cambridge Cognition.

Deborah Estrin, Open mHealth

Deborah Estrin, Open mHealth

Deborah Estrin is co-founder of Open mHealth.

Adrian Aoun, Forward

Adrian Aoun, Forward

Adrian Aoun is the CEO and founder of Forward.

John Lieberman, NYC Medtech

John Lieberman, NYC Medtech

John Lieberman is the founder of NYC Medtech.

Rick Altinger, Glooko

Rick Altinger, Glooko

Rick Altinger is CEO of Glooko.

Tom Kottler, HealthPrize Technologies

Tom Kottler, HealthPrize Technologies

Tom Kottler is co-founder and CEO of HealthPrize Technologies.

Dr. John Brownstein, Circulation

Dr. John Brownstein, Circulation

Dr. John Brownstein is cofounder of Circulation and chief innovation officer at Boston Children's Hospital.

Libbe Englander, Pharm3r

Libbe Englander, Pharm3r

Libbe Englander is founder and CEO of Pharm3r.

Brandi Davis-Dusenbery, Seven Bridges

Brandi Davis-Dusenbery, Seven Bridges

Brandi Davis-Dusenbery is CEO of Seven Bridges.

Dr. Amy Baxter, MMJ Labs

Dr. Amy Baxter, MMJ Labs

Dr. Amy Baxter is founder and CEO of MMJ Labs.

Dr. Robert Robbins, Texas Medical Center

Dr. Robert Robbins, Texas Medical Center

Dr. Robert Robbins is president and CEO of the Texas Medical Center.

Lynn O'Connor Vos, ghg

Lynn O'Connor Vos, ghg

Lynn O'Connor Vos is CEO of ghg.

Olivier Noel, DNAsimple

Olivier Noel, DNAsimple

Olivier Noel is founder and CEO of DNAsimple.

Thomas Goetz, Iodine

Thomas Goetz, Iodine

Thomas Goetz is the CEO and co-founder of Iodine.

Amy Molyneux, Meta

Amy Molyneux, Meta

Amy Molyneux is co-founder and EVP of Meta.

Melinda Richter, Johnson & Johnson

Melinda Richter, Johnson & Johnson

Melinda Richter is head of JLABS at Johnson & Johnson.

Top 40 Healthcare Transformers of 2017

Top 40 Healthcare Transformers of 2017

MM&M honors 40 upstarts and veteran innovation gurus.

Nothing Will Replace Human Doctors, Not Even Robots

Nothing Will Replace Human Doctors, Not Even Robots

Healthcare is one industry that hangs in this delicate balance, in large part due to the fact that it necessitates a blend of science and empathy.

MM&M Startup Showdown connects startups with biopharma execs

MM&M Startup Showdown connects startups with biopharma execs

This program is designed to enable entrepreneurs and biopharma marketers to engage in an intelligent way to explore beyond-the-pill partnerships.

From SXSW: Learnings for Healthcare Marketers from the NYT and WWE

From SXSW: Learnings for Healthcare Marketers from the NYT and WWE

As we build health solutions, making decisions in office parks and around conference tables, it's easy to lose the individual person through the scale of our work.

Monday at SXSW: That's a wrap

Monday at SXSW: That's a wrap

SXSW's health track finally got a seat at the big-kids table.

Sunday at SXSW: Healthcare costs and cancer

Sunday at SXSW: Healthcare costs and cancer

A high-profile cancer track commands attention, while wearables and IBM Watson Health come under fire.

Saturday at SXSW: Hooray for health

Saturday at SXSW: Hooray for health

The first days at SXSW Health went deep on entrepreneurship and the marketing thereof.

Klara's Simon Lorenz on breaking away from the physician lifestyle

Klara's Simon Lorenz on breaking away from the physician lifestyle

He instead decided to find a way to make a physician's job easier by creating a clinical messaging platform.

Five things for pharma marketers to know: Monday, March 6, 2017

Five things for pharma marketers to know: Monday, March 6, 2017

Gilead exec blames PBMs for high drug prices; Google uses AI to detect signs of breast cancer; Sanofi and Regeneron drug effective in treating eczema

Cigna partners with Microsoft HoloLens on biometric game

Cigna partners with Microsoft HoloLens on biometric game

The health insurer partnered with Microsoft to use VR and AR technology to gather biometric data.

Five things for pharma marketers to know: Friday, February 17, 2017

Five things for pharma marketers to know: Friday, February 17, 2017

Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March

How can drugmakers tell better stories? Try Instagram

How can drugmakers tell better stories? Try Instagram

The Kim Kardashian debacle aside, what makes the platform so potentially valuable to pharma and healthcare marketers is its visual story-telling capability.

10 ways healthcare companies are testing Instagram

10 ways healthcare companies are testing Instagram

Pharmaceutical and healthcare companies use a mix of corporate and brand accounts on Instagram, and some are turning to celebrity influencers.

BreathResearch's Nirinjan Yee on being a female entrepreneur

BreathResearch's Nirinjan Yee on being a female entrepreneur

A bout with Lyme disease led Yee to found a company that helps patients measure and track their breathing patterns.

MM&M's top 5 stories in January 2017

MM&M's top 5 stories in January 2017

Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation

Continuum and Lyft to offer free rides to clinical-trial patients

Continuum and Lyft to offer free rides to clinical-trial patients

Transportation barriers can limit patient involvement in clinical trials.

Five things for pharma marketers to know: Wednesday, January 25, 2017

Five things for pharma marketers to know: Wednesday, January 25, 2017

Novartis forecasts slower growth in 2017; Actelion reports trial failure for PAH drug; HHS nominee Tom Price denies conflict of interest claims

Five things for pharma marketers to know: Wednesday, January 18, 2017

Five things for pharma marketers to know: Wednesday, January 18, 2017

Rep. Price to answer questions at confirmation hearing; 22 drugmakers invest in fighting disease in poor countries; FDA approves generic of Jazz's Xyrem

Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions

Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions

There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.

Healthcare Marketers: The Future is Personal

Healthcare Marketers: The Future is Personal

Nothing is more personal than an individual's health; the technology that will prove most effective will be solutions that are personal.

Five things for pharma marketers to know: Tuesday, January 10, 2017

Five things for pharma marketers to know: Tuesday, January 10, 2017

Illumina and IBM enter DNA sequencing partnership; J&J to outline price increases in new report; Egalet's opioid Arymo ER gets FDA approval

Japanese drugmakers lead the way in digital innovation

Japanese drugmakers lead the way in digital innovation

Otsuka, Astellas, Takeda, and Daiichi Sankyo share a degree of adventurousness and forward-mindedness in the digital realm.

MM&M's new logo reflects the evolving industry

MM&M's new logo reflects the evolving industry

This month we will debut a restyled MM&M logo on our website, in a mobile-friendly, redesigned email newsletter, and on the cover of our magazine.